
KURA vs PCRX
$KURA vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
KURA vs PCRX: the quick read
- ·KURA is the larger company by market cap ($996M vs $993M).
- ·KURA has been more active on our scanner (139 vs 28 alerts in 30 days).
- ·PCRX has the smaller float (34.1M vs 88.7M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·KURA draws far more of our scanner's attention, 139 unusual-volume alerts in 30 days against 28, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing KURA and PCRX on TheDesperateTrader.
- Is KURA or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. KURA is the larger company by market cap ($996M vs $993M). KURA has been more active on our scanner (139 vs 28 alerts in 30 days). PCRX has the smaller float (34.1M vs 88.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between KURA and PCRX?
- The differences that matter: they are not in the same business - KURA is pharmaceutical preparations and PCRX is pharmaceutical preparations; they are similar in size ($996M vs $993M); they trade at very different share prices ($11.79 vs $24.48); KURA sits at 68% of its 52-week range against 64% for PCRX; our scanner flagged KURA 139 times in the last 30 days against 28 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of KURA and PCRX is more active right now?
- Right now KURA is at about 0.9x its normal volume and PCRX is at about 0.6x, so KURA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading KURA or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore KURA and PCRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.